Members of the Board of Directors are organizational stewards who are passionate about endocrine research and practice and are committed to our mission – to unite, lead, and grow the endocrine community to accelerate scientific breakthroughs and improve health worldwide. To learn more about this dynamic group of leaders, please review their bios. If you’d like to become a member leader, learn more today.
President
Nanette Santoro, MD
University of Colorado School of Medicine
Term end: 2028
President-Elect
Joy Wu, MD, PhD
Stanford University
Term end: 2029
Immediate Past President
Carol Lange, PhD
University of Minnesota Masonic Cancer Center
Term end: 2027
Secretary Treasurer
Kristy Brown, PhD
Univ. of Kansas Medical Center
Term ends: 2028
 Cherié Butts, PhDBiogen Term end: 2028 |
 Leonor Corsino, MDDuke University Term end: 2028 |
 Scott Dehm, PhDUniversity of Minnesota Term end: 2029 |
 Bruno Ferraz-de-Souza, MD, PhDUniv. of Notre Dame Australia School of Medicine Term end: 2027 |
 Lauren Fishbein, MD, PhD Univ. of Colorado Term end: 2027 |
 Sherita Golden, MD, MHSJohns Hopkins University Term end 2029 |
 Angela Leung, MDUniversity of California – Los Angeles Term end: 2027 |
 Christopher McCartney, MDWest Virginia University Term end 2029 |
 Patricia Morris, PhDThe Rockefeller University Term end: 2028 |
 Heather Patisaul, PhDNational Institute of Environmental Health Sciences (NIEHS) Term end: 2028 |
 Daniel Spratt, MDMaine Medical Center Term end 2029 |
 David Toro Tobon, MD (Early Career Director)Mayo Clinic Term end 2029 |
Ex-Officio Members
Gail Risbridger, PhD
Ex-Officio, Nominating Committee Chair
Monash University, Australia
Term end: 2027
Join our endocrine community and become a member! Only members receive access to a variety of member benefits that will enhance your career. If your membership has lapsed, rejoin today so that you can continue to receive your membership benefits.
